COMMUNIQUÉS West-GlobeNewswire

Flexion Therapeutics Submits Supplemental New Drug Application (sNDA) for ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
17/12/2018
sNDA aims to revise the product label with new data indicating repeat administration of ZILRETTA was safe and well tolerated BURLINGTON, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) [...]
PhaseBio Appoints Edmund P. Harrigan to Board of Directors
17/12/2018
MALVERN, Pa. and SAN DIEGO, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]
EyePoint Pharmaceuticals Added to NASDAQ Biotechnology Index
17/12/2018
WATERTOWN, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Mid-Valley Hospital and clinic select Cerner CommunityWorks to enhance patient care
17/12/2018
10-year agreement aims to use Cerner to advance health strategy OMAK, Wash., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Mid-Valley Hospital (MVH) has selected Cerner, a global leader in health care technology, to transform its [...]
Inspire Medical Systems, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
17/12/2018
MINNEAPOLIS, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Galapagos reports initiation of ISABELA Phase 3 program with GLPG1690 in patients with Idiopathic Pulmonary Fibrosis (IPF)
17/12/2018
Mechelen, Belgium; 17 December 2018, 22.15 CET - Galapagos NV (Euronext & NASDAQ: GLPG) today announces that it has dosed its first patient in the worldwide ISABELA Phase 3 program with autotaxin inhibitor GLPG1690 [...]
Emergent BioSolutions Receives Health Canada Approval of BioThrax® (Anthrax Vaccine Adsorbed)
17/12/2018
GAITHERSBURG, Md., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that Health Canada has approved the company’s New Drug Submission (NDS) for its anthrax vaccine, BioThrax ® ( [...]
Rubius Therapeutics Added to Nasdaq Biotechnology Index
17/12/2018
CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biotechnology company developing an entirely new class of allogeneic cellular therapies, today announced that the company [...]
Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Trials and Provides Clinical Development Strategy Update
17/12/2018
ACH-4471, First Generation Oral factor D Inhibitor - Proof of Concept Validated in both PNH as Monotherapy and in Combination w/C5 Inhibitor - Proof of Mechanism Validated in C3G, End of Phase 2 Meeting Targeted for 4Q [...]
Aclaris Therapeutics Provides Update on Oral and Topical JAK 1/3 Inhibitor Clinical Trials
17/12/2018
Conference call to be held and accompanying slide deck with photos to be included with Current Report on Form 8-K WAYNE, Pa., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist- [...]
CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA
17/12/2018
BRISBANE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high- [...]
Principia Biopharma Issues Statement About the Passing of Board Member Lewis J. Shuster
17/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Medexus Announces New Chief Executive Officer, Chair of the Board of Directors, Other Organizational Updates and Equity Incentive Grants
17/12/2018
MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “ Company ”) (TSXV: PDP, OTCQB: PDDPF) today announced organizational changes designed to better position the [...]
United Health Products to Hold Conference Call on December 20, 2018 to Discuss Recent Corporate Developments and Provide Year End Update
17/12/2018
HENDERSON, Nev., Dec. 17, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), a manufacturer and marketer of HemoStyp ® , a patented hemostatic gauze for the healthcare and wound [...]
B.C. Honours Excellence in Nursing
17/12/2018
VANCOUVER, British Columbia, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Nurses and Nurse Practitioners of BC (NNPBC), the only professional association in the province representing all four nursing designations, is proud to [...]
Medifirst Solutions Applauds the Passage of the Farm Bill at the American Pain Association Symposium in Philadelphia
17/12/2018
Freehold, NJ, Dec. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”): Speaking at the American Pain Association (APA) symposium held on December 12th [...]
Oryzon to join the IBEX Small Cap Index
17/12/2018
The inclusion will become effective on December 24 th MADRID, Spain and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical [...]
OSE Immunotherapeutics Appoints Julien Perrier Chief Commercial Officer
17/12/2018
Julien Perrier brings extensive immunotherapy business operation experience To prepare the best commercial alliance for Phase 3 NSCLC candidate Tedopi® To strengthen commitment to clinical FR104 CD28 antagonist [...]
ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 10
17/12/2018
LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]

Pages